← Leaderboards
Chiung-Yu Hung
University Of Texas San Antonio
$5,101,104
Attributed
$5,101,104
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,529,104 · 7
By mechanism
U19$7,780,955 · 3
R01$1,899,426 · 1
R21$842,723 · 2
R13$6,000 · 1
Top collaborators
- Jose L. Lopez-Ribot4 shared
Most similar at University Of Texas San Antonio
Same institution · by research overlap
- Jose L. Lopez-Ribot$7,729,701
- Thomas F. Patterson$4,803,300
- Jieh-Juen Yu$1,366,846
- Sarah Beth Saeger$37,513
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesCoccidioidomycosisDesignCoccidioidesAreaCellsUnited StatesImmunityIn VitroLungInfectionTherapeutic DevelopmentReportingBaseMedicalCoccidioides PosadasiiImmunogenicCoccidioides ImmitisAntigen-Presenting CellsAffectClinical TrialsChitinGlucansAttenuated
Grant awards (22)
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.$1,357,000
U19 · FY2025 · AI · contact PI
SA-CCRC Administrative Core$271,401
U19 · FY2025 · AI · contact PI
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis$271,399
U19 · FY2025 · AI · contact PI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.$1,357,000
U19 · FY2024 · AI · contact PI
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis$430,315
U19 · FY2024 · AI · contact PI
SA-CCRC Administrative Core$196,421
U19 · FY2024 · AI · contact PI
Support for the 68th annual meeting of Coccidioidomycosis study group$6,000
R13 · FY2024 · AI · contact PI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.$1,357,000
U19 · FY2023 · AI · contact PI
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis$395,776
U19 · FY2023 · AI · contact PI
SA-CCRC Administrative Core$201,121
U19 · FY2023 · AI · contact PI
SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.$1,357,000
U19 · FY2022 · AI · contact PI
Project #3:Active Vaccination and Immunotherapy Against Coccidioidomycosis$387,539
U19 · FY2022 · AI · contact PI
Development of a multivalent vaccine against Coccidioides infection$378,328
R01 · FY2022 · AI · contact PI
SA-CCRC Administrative Core$198,983
U19 · FY2022 · AI · contact PI
Development of a multivalent vaccine against Coccidioides infection$378,328
R01 · FY2021 · AI · contact PI
Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis$220,750
R21 · FY2021 · AI · contact PI
Development of a multivalent vaccine against Coccidioides infection$378,010
R01 · FY2020 · AI · contact PI
Apply an imaging flow cytometry method to screen chemical libraries for identifying and repurposing novel drugs against coccidioidomycosis$182,668
R21 · FY2020 · AI · contact PI
Development of a multivalent vaccine against Coccidioides infection$377,053
R01 · FY2019 · AI · contact PI
Development of a multivalent vaccine against Coccidioides infection$387,707
R01 · FY2018 · AI · contact PI
Enhancement of protective efficacy of Coccidioides vaccines by adjuvants$191,815
R21 · FY2016 · AI · contact PI
Enhancement of protective efficacy of Coccidioides vaccines by adjuvants$247,490
R21 · FY2015 · AI · contact PI